Evaluation of Sex Differences in the Potential of Δ<sup>9</sup>-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats-Reference-Cited by-同舟云学术

Evaluation of Sex Differences in the Potential of Δ⁹-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats

Published:2022-08-17 Issue: Volume: Page:
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Rock Erin M.¹,Limebeer Cheryl L.¹,Smoum Reem²,Mechoulam Raphael²,Parker Linda A.¹^ORCID

Affiliation:

1. Department of Psychology and Collaborative Neuroscience Program, University of Guelph, Guelph, Canada.

2. Institute of Drug Research, Medical Faculty, Hebrew University of Jerusalem, Jerusalem, Israel.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2022.0158

Reference54 articles.

1. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

2. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

3. Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors

4. Effectiveness of Palonosetron Versus Other Serotonin 5-HT3 Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic Chemotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of anandamide and the endocannabinoids in the treatment and regulation of nausea and vomiting;Anandamide in Health and Disease;2025

2. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy;Experimental Neurology;2023-02

3. Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures;Experimental Neurology;2023-01

4. Use of Cannabis and Cannabinoids for Treatment of Cancer;Cancers;2022-10-20